Saturday, June 20, 2020

Pharma Reviews: India can take on China in API sector but not without govt easing regulation, say pharma giants

The manufacture of drugs in India, many life-saving, is dependent on sourcing raw material or active pharmaceutical ingredients (APIs) from China.
Read more: India can take on China in API sector but not without govt easing regulation, say pharma giants